Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/prognostic-factors-in-pediatric-acute-myeloid-leukemia-6PKHRJV0Ll
References (58)
-
L. Maurillo, F. Buccisano, M. Principe, G. Poeta, A. Spagnoli, P. Panetta, E. Ammatuna, B. Neri, L. Ottaviani, C. Sarlo, Daniela Venditti, M. Quaresima, R. Cerretti, M. Rizzo, P. Fabritiis, F. Coco, W. Arcese, S. Amadori, A. Venditti (2008)
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 30
-
C. Schiffer (2008)
Molecular characterization of AML: a significant advance or just another prognostic factor?Best practice & research. Clinical haematology, 21 4
-
S. Meshinchi, T. Alonzo, Derek Stirewalt, M. Zwaan, M. Zimmerman, D. Reinhardt, G. Kaspers, N. Heerema, R. Gerbing, B. Lange, J. Radich (2006)
Clinical implications of FLT3 mutations in pediatric AML.Blood, 108 12
-
By Grimwade, H. Walker, F. Oliver, K. Wheatley, C. Harrison, G. Harrison, J. Rees, I. Hann, R. Stevens, A. Burnett, A. Goldstone (1998)
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.Blood, 92 7
-
E. Sievers, B. Lange, T. Alonzo, R. Gerbing, I. Bernstein, F. Smith, R. Arceci, W. Woods, M. Loken (2003)
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.Blood, 101 9
-
S. Raimondi, Myron Chang, Yaddanapudi Ravindranath, F. Behm, M. Gresik, C. Steuber, Howard Weinstein, Andrew Carroll (1999)
Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.Blood, 94 11
-
S. Botton, V. Coiteux, S. Chevret, C. Rayón, E. Vilmer, M. Sanz, J. Serna, N. Philippe, A. Baruchel, G. Leverger, A. Robert, J. Miguel, E. Conde, J. Sotto, D. Bordessoule, N. Fegueux, M. Fey, A. Parry, C. Chomienne, L. Degos, P. Fenaux (2004)
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 8
-
(2007)
Abstract 1429. Four-color flow MRD is now being considered as an important method that will significantly change our future risk stratification and how we manage AML -
J. Pollard, R. Zeng, Phoenix Ho, T. Alonzo, R. Gerbing, Derek Stirewalt, N. Heerema, S. Raimondi, B. Hirsch, J. Franklin, B. Lange, S. Meshinchi (2008)
Prevalence and Prognostic Implications of WT1 Mutations in Pediatric AML Â: Report from Children’s Oncology GroupBlood, 112
-
B Löwenberg, JR Downing, A Burnett (1999)
Acute myeloid leukemiaN Engl J Med, 341
-
S. Fröhling, R. Schlenk, I. Stolze, Jörg Bihlmayr, A. Benner, S. Kreitmeier, K. Tobis, H. Döhner, K. Döhner (2004)
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 4
-
F. Damm, M. Heuser, M. Morgan, Haiyang Yun, A. Grosshennig, G. Göhring, B. Schlegelberger, K. Döhner, O. Ottmann, M. Lübbert, W. Heit, L. Kanz, G. Schlimok, A. Raghavachar, W. Fiedler, H. Kirchner, H. Döhner, G. Heil, A. Ganser, J. Krauter (2010)
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 4
-
H. Hasle, T. Alonzo, A. Auvrignon, C. Béhar, Myron Chang, U. Creutzig, A. Fischer, E. Forestier, A. Fynn, O. Haas, J. Harbott, C. Harrison, N. Heerema, M. Heuvel-Eibrink, G. Kaspers, F. Locatelli, P. Noellke, S. Polychronopoulou, Y. Ravindranath, B. Razzouk, D. Reinhardt, N. Savva, B. Stark, S. Suciu, I. Tsukimoto, D. Webb, D. Wójcik, W. Woods, M. Zimmermann, C. Niemeyer, S. Raimondi (2007)
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.Blood, 109 11
-
Phoenix Ho, T. Alonzo, R. Gerbing, J. Pollard, Derek Stirewalt, C. Hurwitz, N. Heerema, B. Hirsch, S. Raimondi, B. Lange, J. Franklin, J. Radich, S. Meshinchi (2009)
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.Blood, 113 26
-
particular ineterest, published recently, have been highlighted as: • Of importance -
C. Langebrake, U. Creutzig, M. Dworzak, O. Hrusak, E. Mejstrikova, F. Griesinger, M. Zimmermann, D. Reinhardt (2006)
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 22
-
G. Marcucci, K. Mrózek, A. Ruppert, K. Maharry, J. Kolitz, J. Moore, R. Mayer, M. Pettenati, B. Powell, C. Edwards, L. Sterling, J. Vardiman, C. Schiffer, A. Carroll, R. Larson, C. Bloomfield (2005)
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 24
-
I. Hann, D. Webb, B. Gibson, C. Harrison (2004)
MRC trials in childhood acute myeloid leukaemia.Annals of hematology, 83 Suppl 1
-
V. Gaidzik, R. Schlenk, Simone Moschny, A. Becker, L. Bullinger, A. Corbacioglu, J. Krauter, B. Schlegelberger, A. Ganser, H. Döhner, K. Döhner (2009)
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group.Blood, 113 19
-
R. Stone (2009)
Prognostic factors in AML in relation to (ab)normal karyotype.Best practice & research. Clinical haematology, 22 4
-
J. Pollard, T. Alonzo, R. Gerbing, Phoenix Ho, R. Zeng, Y. Ravindranath, G. Dahl, N. Lacayo, D. Becton, Myron Chang, H. Weinstein, B. Hirsch, S. Raimondi, N. Heerema, W. Woods, B. Lange, C. Hurwitz, R. Arceci, J. Radich, I. Bernstein, M. Heinrich, S. Meshinchi (2010)
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.Blood, 115 12
-
E. Coustan-Smith, Raul Ribeiro, J. Rubnitz, B. Razzouk, C. Pui, S. Pounds, M. Andreánsky, F. Behm, S. Raimondi, S. Shurtleff, J. Downing, D. Campana (2003)
Clinical significance of residual disease during treatment in childhood acute myeloid leukaemiaBritish Journal of Haematology, 123
-
J. Chessells, C. Harrison, H. Kempski, D. Webb, K. Wheatley, I. Hann, R. Stevens, G. Harrison, B. Gibson (2002)
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working partyLeukemia, 16
-
J. Rubnitz, S. Lensing, B. Razzouk, S. Pounds, C. Pui, Raul Ribeiro (2007)
Effect of race on outcome of white and black children with acute myeloid leukemia: The St. Jude experiencePediatric Blood & Cancer, 48
-
K. Wheatley, A. Burnett, A. Goldstone, R. Gray, I. Hann, C. Harrison, J. Rees, R. Stevens, H. Walker (1999)
A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trialBritish Journal of Haematology, 107
-
R. Wells, D. Arthur, A. Srivastava, N. Heerema, M. Beau, T. Alonzo, A. Buxton, W. Woods, WB Howells, D. Benjamin, DL Betcher, J. Buckley, S. Feig, T. Kim, L. Odom, F. Ruymann, W. Smithson, R. Tannous, J. Whitt, L. Wolff, T. Tjoa, B. Lampkin (2002)
Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213Leukemia, 16
-
D. Grimwade, R. Hills (2009)
Independent prognostic factors for AML outcome.Hematology. American Society of Hematology. Education Program
-
B. Cheson, John Bennett, K. Kopecky, T. Büchner, Cheryl Willman, E. Estey, Charles Schiffer, H. Doehner, Martin Tallman, T. Lister, F. Lo‐Coco, R. Willemze, A. Biondi, W. Hiddemann, Richard Larson, B. Löwenberg, Miguel Sanz, David Head, R. Ohno, Clara Bloomfield (2003)
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 24
-
R. Aplenc, T. Alonzo, R. Gerbing, F. Smith, S. Meshinchi, J. Ross, J. Perentesis, W. Woods, B. Lange, S. Davies (2006)
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group.Blood, 108 1
-
I Avivi, JM Rowe (2005)
Prognostic factors in acute myeloid leukemiaCurr Opin Hematol, 12
-
S. Davies, L. Robison, J. Buckley, Thomas Tjoa, W. Woods, G. Radloff, J. Ross, J. Perentesis (2001)
Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 5
-
U. Creutzig, J. Ritter, H. Riehm, Langermann Hj, G. Henze, H. Kabisch, D. Niethammer, H. Jürgens, B. Stollmann, U. Lasson (1985)
Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78.Blood, 65 2
-
B. Balgobind, S. Raimondi, S. Raimondi, J. Harbott, M. Zimmermann, T. Alonzo, A. Auvrignon, H. Beverloo, Myron Chang, U. Creutzig, M. Dworzak, E. Forestier, B. Gibson, H. Hasle, C. Harrison, N. Heerema, N. Heerema, G. Kaspers, A. Leszl, N. Litvinko, L. Nigro, A. Morimoto, C. Pérot, R. Pieters, D. Reinhardt, J. Rubnitz, Franklin Smith, Franklin Smith, J. Starý, I. Stasevich, S. Strehl, T. Taga, D. Tomizawa, D. Webb, Z. Zemanová, C. Zwaan, M. Heuvel‐Eibrink (2009)
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.Blood, 114 12
-
R. Cairoli, A. Beghini, G. Grillo, G. Nadali, F. Elice, C. Ripamonti, P. Colapietro, M. Nichelatti, L. Pezzetti, M. Lunghi, A. Cuneo, A. Viola, F. Ferrara, M. Lazzarino, F. Rodeghiero, G. Pizzolo, L. Larizza, E. Morra (2006)
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.Blood, 107 9
-
K. Mrózek, G. Marcucci, P. Paschka, S. Whitman, C. Bloomfield (2007)
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Blood, 109 2
-
P. Paschka, G. Marcucci, A. Ruppert, K. Mrózek, Hankui Chen, R. Kittles, T. Vukosavljevic, D. Perrotti, J. Vardiman, A. Carroll, J. Kolitz, R. Larson, C. Bloomfield (2006)
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 24
-
(2008)
Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies -
P. Paschka, G. Marcucci, A. Ruppert, S. Whitman, K. Mrózek, K. Maharry, C. Langer, C. Baldus, Weiqiang Zhao, B. Powell, M. Baer, A. Carroll, M. Caligiuri, J. Kolitz, R. Larson, C. Bloomfield (2008)
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 28
-
S. Meshinchi, T. Alonzo, R. Gerbing, J. Pollard, A. Gamis, C. Hurwitz, J. Franklin, L. Pardo, M. Loken (2007)
Minimal Residual Disease Detection by Four-Color Multidimensional Flow Cytometry Identifies Pediatric AML Patients at High Risk of Relapse.Blood, 110
-
B. Lange, R. Gerbing, J. Feusner, J. Skolnik, N. Sacks, F. Smith, T. Alonzo (2005)
Mortality in overweight and underweight children with acute myeloid leukemia.JAMA, 293 2
-
P. Paschka, Juan Du, R. Schlenk, V. Gaidzik, L. Bullinger, A. Corbacioglu, M. Zucknick, A. Benner, F. Stegelmann, D. Späth, S. Kayser, B. Schlegelberger, J. Krauter, A. Ganser, H. Döhner, K. Döhner (2009)
Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG).Blood, 114
-
JE Rubnitz, S Lensing, BI Razzouk (2007)
Effect of race on outcome of white and black children with acute myeloid leukemia: the StJude experience. Pediatr Blood Cancer, 48
-
U. Bacher, C. Haferlach, W. Kern, T. Haferlach, S. Schnittger (2008)
Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.Blood, 111 5
-
K Wheatley, AK Burnett, AH Goldstone (1999)
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council?s Adult and Childhood Leukaemia Working PartiesBr J Haematol, 107
-
M. Elliott, M. Litzow, L. Letendre, R. Wolf, C. Hanson, A. Tefferi, M. Tallman (2007)
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival.Blood, 110 13
-
A. Shimada, T. Taki, K. Tabuchi, A. Tawa, K. Horibe, M. Tsuchida, R. Hanada, I. Tsukimoto, Y. Hayashi (2006)
KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.Blood, 107 5
-
B. Lange, F. Smith, J. Feusner, D. Barnard, P. Dinndorf, S. Feig, N. Heerema, C. Arndt, R. Arceci, N. Seibel, M. Weiman, K. Dusenbery, K. Shannon, S. Luna-Fineman, R. Gerbing, T. Alonzo (2008)
Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.Blood, 111 3
-
Suzie Noronha, J. Farrar, T. Alonzo, R. Gerbing, N. Lacayo, G. Dahl, Y. Ravindranath, R. Arceci, D. Loeb (2009)
WT1 expression at diagnosis does not predict survival in pediatric aml: A report from the Children's Oncology GroupPediatric Blood & Cancer, 53
-
SA Noronha, JE Farrar, TA Alonzo (2009)
WT1 expression at diagnosis does not predict survival in pediatric AMLPediatr Blood Cancer, 53
-
(2009)
This paper emphasizes our evolving knowledge of cytogenetics and molecular genetics and how these risk factors are better delineated through large cooperative studies -
F. Giles, A. Keating, A. Goldstone, I. Avivi, C. Willman, H. Kantarjian (2002)
Acute myeloid leukemia.Hematology. American Society of Hematology. Education Program
-
S Meshinchi, RJ Arceci (2007)
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemiaOncologist, 12
-
D. Breems, W. Putten, G. Greef, S. Zelderen-Bhola, K. Gerssen-Schoorl, C. Mellink, A. Nieuwint, M. Jotterand, A. Hagemeijer, H. Beverloo, B. Löwenberg (2008)
Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 29
-
Iris Hollink, C. Zwaan, Martin Zimmermann, T. Arentsen-Peters, Rob Pieters, J. Cloos, G. Kaspers, S. Graaf, J. Harbott, U. Creutzig, D. Reinhardt, M. Heuvel-Eibrink, Christian Thiede (2009)
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AMLLeukemia, 23
-
S. Meshinchi, F. Smith, R. Arceci (2003)
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemiaCurrent Oncology Reports, 5
-
K. Inokuchi (2012)
[Prognostic factors of acute myeloid leukemia].Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2
-
G. Kaspers, C. Zwaan (2007)
Pediatric acute myeloid leukemia: towards high-quality cure of all patientsHaematologica, 92
-
A. Gamis, W. Woods, T. Alonzo, A. Buxton, B. Lange, D. Barnard, S. Gold, F. Smith (2003)
Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 18
- Publisher
- Springer Journals
- Copyright
- Copyright © 2010 by Springer Science+Business Media, LLC
- Subject
- Medicine & Public Health; Hematology
- ISSN
- 1558-8211
- eISSN
- 1558-822X
- DOI
- 10.1007/s11899-010-0060-z
- pmid
- 20652454
- Publisher site
- See Article on Publisher Site
Abstract
Acute myeloid leukemia (AML), a heterogeneous group of diseases with variable responses to the same therapy, comprises nearly a quarter of childhood acute leukemias. Although historically very few prognostic markers have been incorporated into therapeutic decision making in AML, recent advances in technology have enabled identification of numerous factors associated with disease outcome. This review provides a detailed analysis of most clinically relevant factors associated with disease outcome in childhood AML.
Journal
Current Hematologic Malignancy Reports – Springer Journals
Published: Jul 22, 2010